Mentzer index

From WikiMD's WELLNESSPEDIA

Mentzer Index[edit]

Introduction[edit]

The Mentzer Index is a diagnostic tool in hematology, introduced by William C. Mentzer in 1973. It is a calculation used to differentiate between Iron-deficiency anemia and Beta thalassemia, two common causes of microcytic anemia.

Background and Development[edit]

Developed by William C. Mentzer, the index was created to provide a simple, quick method to distinguish between these two types of anemia using standard blood count results.

Calculation[edit]

The Mentzer Index is calculated from a complete blood count (CBC) and involves the following formula: \[ \text{Mentzer Index} = \frac{\text{Mean Corpuscular Volume (MCV, in fL)}}{\text{Red Blood Cell Count (RBC, in Millions per µL)}} \]

  • A result less than 13 suggests Beta thalassemia.
  • A result greater than 13 indicates iron-deficiency anemia.
Illustration of Complete Blood Count Test

Clinical Significance[edit]

The index is particularly useful in regions where both iron deficiency and thalassemia are common. It aids in:

  • Making preliminary distinctions between these anemias.
  • Guiding further diagnostic testing and treatment planning.

Limitations and Considerations[edit]

While the Mentzer Index is a useful tool, it has limitations:

  • It may not be definitive in all cases, especially in mild forms of anemia.
  • Other factors, such as chronic disease, may influence the results.

Related Diagnostic Tools[edit]

Other indices and tests used in differentiating anemias include:

External Links[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.